Factors influencing low-density lipoprotein cholesterol target achievement in primary care — Results from DYSIS China-Reference-Cited by-同舟云学术

Factors influencing low-density lipoprotein cholesterol target achievement in primary care — Results from DYSIS China

Published:2016-11 Issue: Volume:222 Page:51-56
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Lin Xue,Xu RuiYi,Fang Ligang,Chen Wei,Hu Dayi,Zhao Shuiping,Wang Yongjun,Li Jihu,Yan Xiaowei

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. Cholesterol Treatment Trialists' (CTT) collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins;Baigent;Lancet,2005

2. Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the DYSlipidemia International Study (DYSIS);Zhao;Atherosclerosis,2014

3. A multi-center study of current status on clinical control of hypercholesterolemia in China: success rate and related factors;Chin. J. Cardiol.,2002

4. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries;Kotseva;Eur. J. Cardiovasc. Prev. Rehabil.,2010

5. Impact of lipid-lowering therapy on the prevalence of dyslipidaemia in patients at high-risk of cardiovascular events in UK primary care — a retrospective database study;Jameson;Int. J. Clin. Pract.,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dyslipidemia research landscape and socioeconomic facilitators of scientific productivity in Southeast Asia;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2022-08

2. Prevalence of plasma lipid disorders with an emphasis on LDL cholesterol in selected countries in the Asia-Pacific region;Lipids in Health and Disease;2021-04-15

3. Drug Treatment of Hyperlipidemia in Chinese Patients: Focus on the Use of Simvastatin and Ezetimibe Alone and in Combination;American Journal of Cardiovascular Drugs;2019-02-04

4. Serum FGF21 Is Associated with Future Cardiovascular Events in Patients with Coronary Artery Disease;Cardiology;2018